Novo misses earnings estimate, names new CFO

Novo Nordisk A/S (CSE:NOVOB; NYSE:NVO) reported lower than expected earnings on Thursday, and noted that SVP of Corporate Finance Karsten Munk Knudsen will succeed Jesper Brandgaard as CFO on Feb. 15.

Novo shares slipped DKK24.40 to DKK309 in Copenhagen, and $3.63 to $51.87

Read the full 424 word article

User Sign In